Description
Tirzepatide is a dual-agonist peptide that activates both GLP-1 and GIP receptors, enabling research into the combined incretin effect on insulin secretion, glucagon suppression, and adipose tissue metabolism. HALO Research Supplies provides Tirzepatide as lyophilized peptide confirmed at ≥98% purity by HPLC, with independent COA on every batch.
Available from 5 mg to 100 mg to support dose-escalation and long-duration study designs. Reconstitute in bacteriostatic water; store lyophilized at −20°C.
| Format | Lyophilized powder |
|---|---|
| Purity | ≥98% HPLC |
| Storage | −20°C desiccated |
Research Use Only. Not for human or veterinary use.
